Take TrialScope’s Trial Disclosure Survey
TrialScope has released its second Clinical Trial Disclosure Maturity Survey for sponsors to perform self-assessments of their disclosure practices.
Generics Ride the European Budgetary Control Wave
The European generic drug industry homed in on the opportunity to “help the EU and member states develop effective policies that support access to medicines for patients.”
Clinical Ink and endpoint Ally for Integration
CROS NT Extends Medidata Partnership
endpoint Clinical and Clinical Ink have teamed up to integrate IRT and eSource to create a seamless user experience for investigator sites.
CROS NT announced an extension of its partnership with Medidata to coincide with the launch of its RaveX team.
Orbita and ERT Announce Collaboration
Orbita, a provider of voice-first software for connected home healthcare, announced a collaboration with ERT to research new approaches to data procurement and management.
ERT Introduces Respiratory Solution
ERT has introduced a respiratory clinical trial solution to capture, measure and analyze Lung Clearance Index data.
Can We Predict Drug Efficacy with Artificial Intelligence?
Approaches such as machine learning, AI and neural networks are still in their infancy, but with AI companies rewriting the code for drug discovery, the implications in pharma are likely to be far ranging in the coming years.
Exom Launches First Electronic Informed Consent-eTMF Combo
Exom Launches Electronic Informed Consent-eTMF Combo
Italy-based CRO Exom Group has announced the launch of its electronic informed consent solution, Genius Engage.
Building Quality into Study Startup
With the availability of workflow-based study start-up tools, proactive planning is within reach for stakeholders who view this function as pivotal to improving clinical trial quality.
The Promise of Liquid Biopsy Technology
Examining the potential of such diagnostic technologies in reshaping oncology trials.
Latest Business and People News
Updated employee announcements, business news, awards and recognition in the industry today.
Achieve Sustained Clinical Trials Quality in a Functional Service Provision
Functional service provisions can provide sponsors and CROs with a way to efficiently manage clinical trial outsourcing methods.
Mitigating Supply Chain Risk
Ensuring the supply of clinical drugs during a time of crisis is a necessary moral and ethical action to take. This decision-making framework integrates real-world signals with supply planning techniques to reduce supply chain risk and avoid potential supply interruptions.
Cancer's R&D Convergence
Cancer's R&D Convergence will highlight the changing landscape for clinical trials in this therapeutic area based on the promise of the Cancer MoonShot initiative, along with new oncology immunotherapies.
CISCRP Releases Trials Supplement in USA Today
Belgium Steps Further into Immunotherapies – Highlighting Open European Questions
The Belgian health ministry has decreed that Belgian lung-cancer patients can receive and be reimbursed for immunotherapy treatments.
CISCRP has shared a recent supplement on clinical trials in USA Today magazine.
Mining Cancer Kryptonite from Historic Clinical Trial Data
Clinical trial data from completed trials are now beginning to be shared through a variety of channels. While skeptics remain, evidence is growing that this data can lead to practice-changing behavior in patient care.
DrugDev, Citeline Partner to Integrate Data
DrugDev and Citeline, part of Informa’s Pharma Intelligence vertical, announced that data from Citeline’s Trialstrove and Sitetrove platforms have been integrated.
INC Research and inVentiv Health to Merge
INC Research and inVentiv Health announced that their Boards of Directors have unanimously approved a merger agreement.
Japanese Firm Selects iCardiac for Oncology Trial
iCardiac announced that it has been selected to work on an early phase oncology clinical trial with a global Japanese pharma company.
ERT Acquires Imaging Solution from Cleveland Clinic